Ogier has assisted Medicxi Ventures, formerly Index Ventures Life Sciences, with its formation as an independent life sciences firm. Medicxi Ventures comprises all of the existing life sciences portfolio companies, funds and team from Index Ventures. The Ogier team also worked with Medicxi Ventures on the establishment of Medicxi Ventures
Quercus Assets Selection and Swiss Life Asset Managers have completed a deal to acquire Antin Solar Investments (ASI) in a 50:50 joint venture. ASI now operates as Azienda Solare Italiana Spa. On 18 December 2015 the joint venture, called Quercus Swiss Life Italian Solar Srl, had entered into a binding
Speyside Private Fund Advisers, a special situations buyout firm, has held the closing of Speyside Equity Fund I, a USD130 million buyout fund that will focus on investment opportunities in specialty chemicals, industrials/metal forming & food ingredients businesses and continue the disciplined investment approach that Speyside has successfully executed for
G-Therapeutics has secured up to EUR26 million in a Series A financing round from an investment syndicate consisting of Gimv, Wellington Partners, LSP and Inkef Capital alongside the company’s founders/management. This investment will fund the company’s clinical trials up to CE mark (EU) and IDE (US) approval. G-Therapeutics (http://gtherapeutics.com/#About) develops
BFF Nonwovens has secured a multi-million pound funding package from BGF (Business Growth Fund) and Lloyds Bank to pursue its growth ambitions in the UK and overseas. Based in Bridgwater, Somerset, the company specialises in the production of high quality, bespoke technical fabrics for niche markets. Its products have a
Chemical technology company Avantium has closed a financing round of EUR20 million led by PMV, an independent investment company for Flanders, FPIM, a Belgian Federal Holding and Investment Company, and Avantium’s existing shareholders. The funds will be used to commercialize the YXY technology for producing 100 per cent biobased packaging
The Chartered Alternative Investment Analyst (CAIA) Association, a global leader in alternative investment education, has embarked on its first international branding campaign. Titled “Mind the Gap,” CAIA’s new campaign incorporates creative advertising in the London Underground system, social media outreach to CAIA Members and prospective Members, and educational events designed
Edmond de Rothschild Asset Management has launched the Edmond de Rothschild Fund UK Synergy, available through the Edmond de Rothschild Fund UCITS umbrella domiciled in Luxembourg. The equity fund seeks to capture upside on UK stocks that are possible bid targets and/or undergoing restructuring. Edmond de Rothschild Fund UK
Ambienta has led the acquisition of Calucem Group (Calucem) from ARGUS Capital Partners II. Calucem ranks No2 in the world as a Calcium Aluminate Cements (CAC) developer, manufacturer and distributor and is one of only a few competitors with global reach in the sector. With annual revenues approaching EUR50 million,
z9 Capital (z9) has launched a USD25 million venture capital fund at eMerge Americas. z9 invests USD250,000-USD4 million in early-stage, founder-led companies that have demonstrated product-market fit and are seeking growth capital. z9’s investment thesis is rooted in active management and is the first of its kind, in South Florida,
12 November, 2026 – 5:00 pm
12 November, 2026 – 8:00 am
12 February, 2026 – 8:00 am
12 February, 2026 – 5:00 pm
